Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umang Swami

Showing results (41-50 of 170) with videos related to

Pageof 17
Sort By:
Expert Review of Anticancer Therapy|July 22, 2022
Relugolix in the management of prostate cancerKamal Kant Sahu, Nishita Tripathi, Neeraj Agarwal, et al.
Annals of Translational Medicine|April 30, 2019
Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvementUmang Swami, Roberto H Nussenzveig, Benjamin Haaland, et al.
Cancer Management and Research|June 18, 2020
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular CarcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Cancer Treatment and Research Communications|October 26, 2021
Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment: An illustrative case reportTaylor Ryan McFarland, Clara Elizabeth Tandar, Neeraj Agarwal, et al.
European Urology|September 24, 2024
Correlating Prostate-specific Antigen Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment: Refining Predictive and Prognostic BiomarkersChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal, et al.
JCO Precision Oncology|December 18, 2024
Assessing Nectin-4 as a Predictive Biomarker in Urothelial Carcinoma and Other Genitourinary MalignanciesZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Advanced stage melanoma therapies: Detailing the present and exploring the futureChelsea Luther, Umang Swami, Jun Zhang, et al.
Life (Basel, Switzerland)|February 24, 2024
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic LandscapeAshaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, et al.
Drugs|December 28, 2020
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate CancerNityam Rathi, Taylor Ryan McFarland, Roberto Nussenzveig, et al.
Melanoma Research|August 8, 2018
Toxicities with targeted therapies after immunotherapy in metastatic melanomaNicole Grogan, Umang Swami, Aaron D Bossler, et al.
Pageof 17

Showing results (41-50 of 170) with videos related to

Sort By:
Pageof 17
Expert Review of Anticancer Therapy|July 22, 2022
Relugolix in the management of prostate cancerKamal Kant Sahu, Nishita Tripathi, Neeraj Agarwal, et al.
Annals of Translational Medicine|April 30, 2019
Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvementUmang Swami, Roberto H Nussenzveig, Benjamin Haaland, et al.
Cancer Management and Research|June 18, 2020
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular CarcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Cancer Treatment and Research Communications|October 26, 2021
Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment: An illustrative case reportTaylor Ryan McFarland, Clara Elizabeth Tandar, Neeraj Agarwal, et al.
European Urology|September 24, 2024
Correlating Prostate-specific Antigen Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment: Refining Predictive and Prognostic BiomarkersChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal, et al.
JCO Precision Oncology|December 18, 2024
Assessing Nectin-4 as a Predictive Biomarker in Urothelial Carcinoma and Other Genitourinary MalignanciesZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Advanced stage melanoma therapies: Detailing the present and exploring the futureChelsea Luther, Umang Swami, Jun Zhang, et al.
Life (Basel, Switzerland)|February 24, 2024
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic LandscapeAshaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, et al.
Drugs|December 28, 2020
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate CancerNityam Rathi, Taylor Ryan McFarland, Roberto Nussenzveig, et al.
Melanoma Research|August 8, 2018
Toxicities with targeted therapies after immunotherapy in metastatic melanomaNicole Grogan, Umang Swami, Aaron D Bossler, et al.
Pageof 17